Subi Oh

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

S.-E. Lee, Soo Young Choi, Ho Young Song et al. · Haematologica · 2016 · 165 citations · Full text

Nursing, Pharmacotherapy, Molecular Oncology +14

Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients

Sook Jin Seong, Minkyung Lim, Sang Kyun Sohn et al. · Annals of Oncology · 2012 · 79 citations · Full text

Veterinary Medicine, Pharmacokinetics, Pharmacology +15

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors

S.-H. Kim, Hari Menon, Saengsuree Jootar et al. · Haematologica · 2014 · 70 citations · Full text

Medicine, Oncology, Pharmacology +13